FXH ETF Research - First Trust Health Care AlphaDEX

First Trust Health Care AlphaDEX (fxh)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 118

Threats + Weaknesses = 80

When strengths & opportunities substantially exceed threats & weaknesses an investment in the fxh ETF has great long term potential.

ETF Description Update

First Trust Health Care AlphaDEX (FXH) Description: FXH is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. FXH exchange trading fund (ETF) tracks the StrataQuant Health Care; the strataquant health care index is an "enhanced" index developed, maintained and sponsored by the nyse euronext or its affiliates which employs the alphadex stock selection methodology to select health care stocks from the russell 1000 index. First Trust Health Care AlphaDEX (FXH) falls under the Health & Biotech Equities category. FXH's dividend yield is roughly 0%, it has an expense ratio of 0.7%, and is in the equity ETF asset class. First Trust Health Care AlphaDEX (FXH) focuses its investments in the U.S. region of the world. FXH does not use leverage and FXH's performance is meant to match its benchmark. The FXH ETF belongs to the Health & Biotech sector. An investor can find FXH's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features FXH's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on First Trust ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain First Trust Health Care AlphaDEX (FXH)'s strategy.

Performance Analysis Update